Ramsay Health Care Limited

Ramsay Health Care Limited

RMSYF
Ramsay Health Care LimitedUS flagOther OTC
24.61
USD
- -
- -
5.68BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
20.61
24.41
36.42
43.03
43.06
45.37
57.25
57.34
54.23
57.43
65.22
72.47
77.04
Basic EPS, GAAP
1.25
1.44
1.85
2.18
2.4
1.9
2.68
1.36
1.97
1.2
1.31
3.89
0.1
Free Cash Flow per Basic Share
0.92
1.57
1.29
1.96
2.24
-2.35
-2.95
-3.27
-2.76
-3.11
-3.16
-3.3
-3.39
Dividend per Share
0.71
0.83
1.51
1.17
1.35
1.52
1.6
1.61
0.55
1.63
1.04
0.69
0.83
Book Value per Share
6.45
7.11
7.9
8.96
10.14
10.58
11.56
17.07
17
16.83
17.27
20.5
19.87
Tangible Book Value per Share
1.55
1.63
-1.48
-1.32
0.34
0.91
-5.72
-0.05
1.39
-5.59
-5.88
-2.68
-3.15
Basic Weighted Avg Shares
201
201
201
201
201
201
201
208
228
228
228
228
229
Sales/Revenue/Turnover
4,134
4,909
7,320
8,648
8,667
9,137
11,513
11,933
12,348
13,082
14,863
16,560
17,674
Operating Margin (%)
9.83
10.19
9.69
9.22
9.59
7.56
8.17
3.6
1.42
1.76
3.73
5.03
4.93
Depreciation Expense
147
170
306
374
374
392
486
893
899
928
989
1,082
1,126
Net Income, GAAP
266
304
386
450
489
388
545
284
449
274
298
889
24
Effective Tax Rate (%)
30.59
29.97
34.55
27.88
26.5
32.36
32.41
33.68
31.03
29.58
34.43
31.54
54.52
Profit Margin (%)
6.44
6.19
5.27
5.21
5.64
4.25
4.74
2.38
3.64
2.09
2.01
5.37
0.14
Working Capital
186
-32
-517
-150
58
373
262
288
1,634
-439
85
-308
-425
LT Debt
1,242
1,334
2,724
3,327
3,262
3,852
5,488
9,137
10,132
10,301
11,400
10,332
11,434
Total Equity
1,542
1,744
1,833
2,046
2,359
2,447
3,023
4,236
4,551
4,526
4,823
5,528
5,709
Return on Invested Capital (%)
10.55
11.77
11.41
10.88
10.83
7.68
8.41
2.54
0.83
1.06
2.27
3.42
2.3
Return on Capital (%)
11.73
11.89
10.71
9.2
9.26
7.48
8.75
2.89
3.51
1.81
2.54
6.89
0.92
Return on Common Equity (%)
20.14
21.29
24.64
25.81
25.13
18.3
24.22
9.67
12.1
7.11
7.67
20.62
0.52

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.56%
6.27%
3.28%
Free Cash Flow
-8.43%
2.88%
3.02%
Net Income, GAAP
12.61%
25.75%
-97.3%
Sales/Revenue/Turnover
9.46%
8.24%
6.73%
Total Cash Common Dividend
10.56%
17.01%
20.47%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
14,863
2024
- -
- -
- -
- -
16,560
2025
- -
- -
- -
- -
17,674

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.31
2024
- -
- -
- -
- -
3.89
2025
- -
- -
- -
- -
0.1

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.04
2024
- -
- -
- -
- -
0.69
2025
- -
- -
- -
- -
0.83

Company Description

APIChat
CEO
Natalie Davis
Full Time Employees
90,000
Sector
Healthcare
Industry
Medical - Care Facilities
Address
126 Phillip Street Sydney NSW Australia 2000
IPO Date
Jun 9, 2010
Business
Ramsay Health Care Limited (ASX:RHC; OTC:RMSYF) operates as a multinational private healthcare provider, owning and managing a global network of hospitals, day surgery facilities, primary care clinics, diagnostics centers, mental health services, rehabilitation units, community pharmacies, and at-home telehealth offerings. The company delivers integrated services encompassing surgical procedures including orthopaedics, cardiology, oncology, maternity, and general surgery; psychiatric care and residential mental health programs; rehabilitation and psychology outpatient treatments; imaging and diagnostic services; and specialized primary care such as cancer support, allied health, virtual monitoring, and community-based nursing. Founded in 1964 by Paul Ramsay in Sydney, Australia, where it maintains headquarters, Ramsay conducts operations across Australia, the United Kingdom, France, Indonesia, Malaysia, Denmark, and other European markets, serving millions of patients annually through over 400 facilities and employing more than 90,000 staff focused on high-quality clinical outcomes and research. In recent developments, Ramsay completed the acquisition of COSEM primary care clinics in France in June 2024, contributing significantly to revenue growth; announced a $190 million expansion of Joondalup Private Hospital in Western Australia including six new operating theatres and 82 beds set to open in early 2026 alongside a 15-year extension of its public-private partnership at Joondalup Health Campus to 2043; and advanced leadership initiatives through the Ramsay Australia Leadership Academy launched in late 2023 while partnering with Health Careers International and Arizona State University to address nursing workforce shortages. Natalie Davis serves as CEO-elect, succeeding Craig McNally in June 2025, amid ongoing investments in digital technologies, robotic surgery capabilities like MAKO systems and Da Vinci platforms, and innovative programs such as vaping cessation clinics and nurse-led cardiac implants.

Company News

APIChat
  • Ramsay Health Care Limited (RMYHY) Q2 2026 Earnings Call Transcript

  • Ramsay Health Care Limited (RMYHY) Discusses Strategic Review Outcome and Proposed Distribution of Ramsay Santé Shares to Shareholders Transcript

  • Australia's Ramsay Health Care to separate from French arm Ramsay Sante

  • Ramsay Health Care Limited (RMYHY) Shareholder/Analyst Call Transcript

  • Australia's Ramsay Health Care posts steep drop in annual profit, shares fall

  • RAMSAY SANTE :Ramsay Health Care Limited Financial advisor announcement - 27 February 2025

  • Australia's Ramsay Health Care mulls potential sale of European arm

  • Australia's Ramsay Health Care Group CFO Martyn Roberts steps down

  • Ramsay Health Care, Sime Darby explore sale of Asia joint venture

  • Australia's Ramsay Health and KKR-led group cease buyout talks